It is not possible to predict the plasma theophylline levels that can be achieved using slow-release aminophylline based on body weight or surface area. Improvement in FEV1 is directly related to increasing serum theophylline level, justifying the need for measuring levels in order to optimize therapy. As repeated venesection in children is unpleasant we have studied a simple method using saliva. Simultaneous blood and salivary theophylline levels correlated sufficiently well for salivary levels to be used for monitoring purposes. Urine levels did not correlate as well, but could be used for checking compliance.
Introduction
The optimum use of theophylline in the treatment of asthma necessitates the measurement of blood levels, as the borderline between efficacy and toxicity is narrow . Blood sampling in children can be unpleasant. This study has been undertaken to assess the value of monitoring theophylline levels in saliva and urine.
Methods
Eighteen children with moderate or severe chronic perennial asthma, aged between 6 and 14 years, were hospitalized for the study. None had intercurrent infections or an acute wheezing episode and no dietary restrictions were imposed. Written consent to participate in the study was obtained from the parents and the project had hospital ethical committee approval. The study was undertaken on patients requiring slow release theophyllines for long-term control of their asthma.
For two days prior to admission and during the first day in hospital no bronchodilator drugs were given, although oral or inhaled steroids were continued. On the second day of study a single dose of slow-release aminophylline (Phyllocontin Continuus, Napp Laboratories) was given at 07:30. The dose chosen was either 10 mg/kg of body weight or the dose previously prescribed. If this did not achieve a serum level of theophylline of between 10 and 20ug/ml for a sustained period during the day, a further day of study was carried out with a higher dose. Forced expiratory volume in one second (FEV1) measurements were made at 07:30, 11:30, 15:30, and 19 :30 on all days. All the results were analysed as a percentage of the predicted value for the patient's height (Cotes 1968) .
Control specimens of blood, urine and saliva were taken from each patient prior to administration of the drug. Serial samples of blood, urine and saliva were then taken at twohourly intervals from 2 to 12 hours after administration of aminophylline, with a small number of omissions depending on the ease of sampling. Prior to venepuncture, a few millilitres of urine were obtained and these samples were saved for analysis. One millilitre samples of blood were collected into heparinized tubes. Immediately after giving the blood specimen the child rinsed his or her mouth out with water. A few drops of lemon juice were squirted onto the tongue from a plastic lemon juice dispenser and the child was told to close 1 Accepted 18 Figure 1 . The dose of slow release aminophylline (Phyllocontin), in mg/kg body weight, administered to 18 children, 12 of whom were studied twice, plotted against the plasma theophylline level achieved at four hours (r = 0.45) the mouth and taste the juice for between 15 and 30 seconds. A specimen of saliva was then collected using a mucus extractor, with the end of the suction tubing held close to the parotid duct: between 0.5 ml and 0.3 ml could be obtained with ease. The specimens were frozen and subsequently theophylline levels were measured.
The enzyme multiplied immunoassay technique (EMIT; SYVA Chemicals) was employed in the measurement of theophylline levels. This assay is based on competitive protein binding using an enzyme as a label and an antibody as a specific binding protein. The enzyme activity is related to the amount of drug in the sample and is measured spectrophotometrically. Standard curves were obtained for each type of sample prior to analysis of the specimen, i.e. known quantities of theophylline were added to blank plasma, urine and saliva samples and assayed using the EMIT. Results A single dose of slow-release aminophylline was given and two-hourly blood samples obtained over a 12 hour period. The plasma theophylline measured four hours after administering the drug was within I uig/ml of the peak level achieved at any time over the 12 hours of study. The four-hour level was chosen to represent the plateau achieved, and Figure  1 shows the relationship between this plateau and the dose administered in mg/kg body weight. The correlation coefficient was 0.45. When the dose was evaluated in relation to body surface area the correlation coefficient was 0.55.
The rise in FEV, as a percentage of predicted value, on a treatment day, compared with the non-treatment day, was plotted against serum theophylline levels (r = 0.64) ( Figure 2 ). Those children who attained 100% of the predicted value for their height (shown as heavy dots) could not reasonably be expected to improve further. If these are excluded from analysis the correlation coefficient was 0.75.
Sixty-five simultaneous blood and saliva samples were obtained and the correlation coefficient between theophylline levels in the matched specimens was 0.89 (Figure 3 ). The linear regression equation was: y = 1.8936x+0.2324, where y = blood level and x = saliva level.
The correlation coefficient between urine and blood theophylline level was 0.65 (Figure 4 ), and was not significantly different if the urine theophylline to creatinine ratio was used.
Discussion
The prescribing of theophylline and aminophylline preparations in the United Kingdom is often based on the manufacturer's recommendations, which are generally conservative in view of potential toxic side effects. McKenzie & Baillie (1978) recommended guidelines for dosage of the slow-release aminophylline and theophylline preparations. They recommended 14 mg/kg body weight as the average paediatric requirement when using Phyllocontin Continuus. Whilst we found a significant correlation between the level achieved and the dose, there was a wide range, between 7 and 18 ,ug/ml, in the blood following the recommended dose. Therefore it was not possible to predict the plasma level that would be achieved by basing dose on either body weight or surface area.
Previous studies using theophylline in asthmatic patients have shown that efficacy is proportional to serum concentration of the drug (Turner-Warwick 1957) , and that toxicity is more likely if levels of greater than 20 pg/ml are achieved (Piafsky & Ogilvie 1975) . The most commonly quoted therapeutic range for theophylline is 10-20 jig/ml , Figure 4 . Simultaneous urine and plasma theophylline levels in 18 children studied on several theophylline levels in 18 children studied on several occasions, following a single dose of slow release occasions, following a single dose of slow release aminophylline; r = 0.89. The line of identity, aminophylline; r = 0.65 saliva :plasma = 1 :2, is indicated although it has been shown that levels as low as 5 ,ug/ml produce a significant bronchodilator effect in asthmatic children (Weinberger & Bronsky 1974) . Our studies confirmed that the improvement in lung function, as measured by the FEVI, was correlated with plasma theophylline concentration, though the drug was sometimes effective at low levels. Amongst those who did not reach their predicted FEV1, greater improvements were achieved the higher the plasma level of theophylline. Venepuncture in children can be unpleasant and attempts to measure theophylline levels in saliva have been made by several previous workers (Lena et al. 1980) . There is still a conflict of opinion about their value. Danhoff and Breimer (1978) held the view that salivary theophylline levels would not be useful as there was considerable inter-and intra-subject variability in the absorption, metabolism and excretion of the drug. American studies on salivary theophylline levels have shown consistent ratios of plasma to salivary theophylline in individuals, although results were assessed on fairly small numbers of samples (Galant et al. 1977) .
A technique for sampling saliva using mucus extractors (Bacon et al. 1978 ) has previously been described for measuring phenobarbitone levels. The method we have developed is simple, reliable and involves stimulation of salivary flow. The good correlation between blood and salivary theophylline levels in our study was probably due to the stimulation of a constant flow of saliva with selective collection of a pure parotid sample. The previously published conflicting results may have arisen from inconsistent stimulation and collection of mixed salivary specimens.
The EMIT technique for measuring theophylline in blood, urine and saliva was chosen because it is simple, specific and reproducible. Access to an automatic spectrophotometer is required. The most common methods for theophylline assay are high performance liquid chromatography and the EMIT. The correlation between them is good (Weidner et al. 1979 ), but the former, although cheaper to run, requires more technician time and an initial expensive outlay on equipment.
Theophylline has not previously been measured in urine from children. The urinary levels in 18 asthmatic children, although correlating significantly with blood, were not as consistent as the salivary levels and we feel that the only practical use of the measurement would be in monitoring compliance with therapy.
Our method of salivary sampling was sufficiently accurate to allow prediction of plasma levels from the salivary values obtained to within + 1 jig/ml on 95%O of occasions. For practical purposes, blood theophylline levels were twice the salivary level. It is our opinion that this method is ideal for paediatric practice and is necessary if theophylline medications are used in childhood.
